End-of-day quote
Egyptian Exchange
06:00:00 2024-04-27 pm EDT
|
5-day change
|
1st Jan Change
|
7.02
EGP
|
-4.36%
|
|
-15.83%
|
-48.19%
|
Fiscal Period: June |
2019
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,349
|
4,260
|
10,715
|
8,330
|
-
|
-
|
Enterprise Value (EV)
1 |
5,349
|
4,260
|
10,715
|
14,106
|
12,967
|
11,638
|
P/E ratio
|
-
|
-
|
9.31
x
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
3.15%
|
3.46%
|
3.99%
|
Capitalization / Revenue
|
15.7
x
|
0.96
x
|
1.62
x
|
1.26
x
|
1.12
x
|
1.11
x
|
EV / Revenue
|
15.7
x
|
0.96
x
|
1.62
x
|
2.14
x
|
1.75
x
|
1.55
x
|
EV / EBITDA
|
-47.1
x
|
-
|
3.59
x
|
5.2
x
|
4.91
x
|
4.44
x
|
EV / FCF
|
-
|
-
|
3.96
x
|
6.86
x
|
6.07
x
|
5.37
x
|
FCF Yield
|
-
|
-
|
25.3%
|
14.6%
|
16.5%
|
18.6%
|
Price to Book
|
-
|
-
|
1.48
x
|
1.02
x
|
0.95
x
|
0.88
x
|
Nbr of stocks (in thousands)
|
892,988
|
1,186,579
|
1,186,579
|
1,186,579
|
-
|
-
|
Reference price
2 |
5.990
|
3.590
|
9.030
|
7.020
|
7.020
|
7.020
|
Announcement Date
|
9/22/19
|
10/25/22
|
10/4/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
341.1
|
-
|
4,441
|
6,612
|
6,604
|
7,423
|
7,522
|
EBITDA
1 |
-113.5
|
-
|
-
|
2,988
|
2,714
|
2,643
|
2,624
|
EBIT
1 |
-142.1
|
-
|
-
|
2,153
|
1,928
|
1,846
|
1,816
|
Operating Margin
|
-41.67%
|
-
|
-
|
32.57%
|
29.19%
|
24.87%
|
24.14%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
1,486
|
1,128
|
1,200
|
1,364
|
Net income
1 |
-
|
-1,350
|
-
|
1,151
|
874
|
965
|
1,108
|
Net margin
|
-
|
-
|
-
|
17.4%
|
13.23%
|
13%
|
14.73%
|
EPS
|
-
|
-
|
-
|
0.9698
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
2,707
|
2,055
|
2,136
|
2,167
|
FCF margin
|
-
|
-
|
-
|
40.94%
|
31.12%
|
28.78%
|
28.81%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
90.59%
|
75.72%
|
80.82%
|
82.58%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
235.25%
|
235.13%
|
221.35%
|
195.58%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
0.2210
|
0.2430
|
0.2800
|
Announcement Date
|
9/22/19
|
11/10/21
|
10/25/22
|
10/4/23
|
-
|
-
|
-
|
Fiscal Period: June |
2020 S1
|
2022 Q1
|
2023 Q3
|
---|
Net sales
|
-
|
987.6
|
-
|
EBITDA
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
Net income
1 |
-
|
122
|
495.6
|
Net margin
|
-
|
12.36%
|
-
|
EPS
2 |
0.0479
|
-
|
0.4206
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
2/13/20
|
12/30/21
|
5/17/23
|
Fiscal Period: June |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
5,776
|
4,637
|
3,308
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
2.128
x
|
1.754
x
|
1.261
x
|
Free Cash Flow
1 |
-
|
-
|
-
|
2,707
|
2,055
|
2,136
|
2,167
|
ROE (net income / shareholders' equity)
|
0.7%
|
-
|
17.2%
|
19%
|
11.4%
|
11.4%
|
12.2%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
6.110
|
6.850
|
7.360
|
7.970
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
42.5
|
417
|
202
|
202
|
Capex / Sales
|
-
|
-
|
-
|
0.64%
|
6.31%
|
2.72%
|
2.69%
|
Announcement Date
|
9/22/19
|
11/10/21
|
10/25/22
|
10/4/23
|
-
|
-
|
-
|
Last Close Price
7.02
EGP Average target price
14.39
EGP Spread / Average Target +104.99% Consensus |
1st Jan change
|
Capi.
|
---|
| -48.19% | 182M | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | +6.39% | 11.24B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B |
Diversified Chemicals
|